The main goal is to strengthen cross-border cooperation between research institutions and companies in fields of medicine, biotechnology and innovation by developing a 3D-printed in vitro skin model for evaluation of the safety and effectiveness of drugs.

Supported from EFRR, project duration: 1.7.2024 – 30.6.2027

 

At Enantis, we are dedicated to innovations in protein engineering, and we are proud to be part of the international ACCURE project. This ambitious initiative pushes the boundaries of regenerative medicine with a unique 3D-printed in vitro skin model.

The ACCURE project (ATCZ00083), funded by the Interreg Austria-Czech Republic program, brings together leading scientific institutions and tech companies from Austria and the Czech Republic. Its goal is to develop an innovative skin model that closely simulates human skin and facilitates the testing of new therapeutics and materials. This breakthrough will accelerate drug development while minimizing animal testing.

The project’s key partners include Brno University of Technology, Masaryk University, Johannes Kepler University Linz, PROFACTOR GmbH, and others. We are honored that Enantis is one of the key contributors to this initiative.

Our expertise in developing hyperstable proteins, particularly fibroblast growth factors (FGFs), plays a crucial role in this project. FGFs are bioactive proteins that support tissue regeneration, including skin repair.

Within the ACCURE project, we focus on:

  • Integrating our hyperstable FGFs into the 3D-printed skin model to ensure it closely mimics real skin and effectively supports therapeutic testing.
  • Optimizing the biological properties of proteins to accelerate wound healing and enhance the functionality of the developed model.
  • Sharing our biotechnological expertise and collaborating with other partners to validate and test the model.

Thanks to the ACCURE project, we are advancing toward our goal of creating effective solutions for healing acute and chronic wounds. Our FGFs have proven to be a key element in these innovations, and we are committed to leveraging biotechnology for the benefit of science and society.

Learn more about the project here: ACCURE – official project page